A particular kind of particle accelerator used in the detection and treatment of cancer is called a medical cyclotron. Charged particles are propelled by electromagnetic fields, creating radioactive isotopes that can be used to make medicines. Additional applications for these isotopes include positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for the detection and planning of cancer. Medical cyclotrons generate less hazardous waste than radioisotope-producing research reactors.
Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS10439/
Market Trends and Drivers
medical imaging is driving up demand for cyclotron systems, and these systems may be used for various diagnostic procedures. Medical cyclotrons are more in demand as a result of the electrically driven device’s ability to produce a beam of charge that is primarily employed in industrial, research, and medical procedures. Except for the negative charge, the hybrid atom that makes up water is held in the new cyclotron machine. The radioactive new element created by the collision of positive ions and neutrons is employed as a treatment in medical research, driving demand for medical cyclotrons.
Global Medical Cyclotron Market Segmental Overview
The report analyses the global medical cyclotron market based on the product type, end user, and region.
Request Customization:
https://www.globalinsightservices.com/request-customization/GIS10439/
Major Players in the Global Medical Cyclotron Market
The key players studied in the report are IBA Radiopharma Solutions, Advanced Cyclotron Systems, Best Cyclotron Systems, Inc., Best ABT Molecular Imaging, Inc., Siemens Healthineers, GE Healthcare, IONETIX Corporation, PMB-ALCEN, Sumitomo Heavy Industries, Ltd., and The Japan Steel Works, Ltd. among others.
COVID-19 Impact
The market share and demand for medical cyclotrons both benefited from COVID-19. Medical cyclotron technology is being used to estimate the frequency of the novel coronavirus (COVID-19), which is estimated to range from 30 kHz to 500 kHz. Companies in the medical cyclotron market are taking part in research projects in an effort to develop antiviral drugs that are thought to lessen the detrimental effects of the virus. Companies are placing more attention on genome sequencing to create COVID-19 medicines in order to increase the sales of medical cyclotrons.
Recent Developments
January 2022, IBA announced that it had launched a new low-energy and compact-size cyclotron, the Cyclone KEY. The new machine will enable small and medium-sized hospitals to produce their radiopharmaceutical products.
August 2020, The German Health company Siemens Healthineers acquired Varian Medical Systems Inc. in an agreement that values the U.S. manufacturer of cancer treatment equipment and software at $16.4 billion.
October 2019, IBA Radiopharma Solutions, a Belgium-based medical technology company, announced a collaboration with Azrieli Center for Neuro-Radiochemistry at the Center for Addiction and Mental Health (CAMH), a Canada-based mental health hospital and research center, in order to promote research & development in the field of nuclear medicine.
Procure Complete Report (PDF with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS10439/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/